The engines have fired up at last for MDX. ( BPRG ) At long last they are being recognised for the force they will become over the next two years. On the cusp of disclosing huge revenue-earning deals with Global pharmacists. These have been hinted at as being unrolled before the years end, but may be in the next days.You still have time to get in at a bargain-basement price before the SP takes off for real shortly.

but i thought barry always won...i am confused

T
he probably did. i guess it will all come out in the wash eventually. or maybe not?
dont forget that "lost invoice" of his. i wonder if it ever got paid.
aside from that i offer my very sincere condolances to all genuine investors who got caught up in the hype and lost money.
regards to all
jkd

just goes to show, never trust anyone who says"trust me".
hmm! i think i read that somewhere today. anyway, trust has to be earned.
as always just my opinion and please dyor.
regards
jkd

My husband used to tell girls that they could trust him because he was a gynecologist. I'm not really sure to what extent it actually worked......

i would never trust a man that looked at diseased kippers all day

Dr Fish Fingers?

occupational hazard i suppose

So Lexuss has a "truth statement" from TFLBTloldoes it confirm he is now in the Forbes listanyone want to ask him?www.facebook.com/people/Richard-Trevillion/1435000138

Hilary >
My husband used to tell girls that they could trust him because he was a gynecologist. I'm not really sure to what extent it actually worked......I would think it worked perfectlyyou bought it

Does he still keep his hand in Hils ?

:-)

Tabby you got any sln's ?

Dilwhat I would say is we have an eternal hate triangleI cannot see this going away quietly nowthere is obviously plenty of damming evidence out there with a huge fraud case imminent imocertain players are getting desperatebig boys posting with passion
YesterdayLexuss2 >

since January 2009 my sole aim (along with some very loyal and diligent colleagues) has been to obtain best value for ALL shareholders - this aim continues and todays events will not detract from it.

There is so much momentumsomebody is going to crackjust my little opinion on this very big caseglad to see you apologised to jozz.twice

If I'm wrong I got no problem apologising tabby .

I agree that its now down to those with most to lose / gain to scrap it out but my money at the moment is still on not one person being convicted of anything.

You got any slns or do you prefer not to say ?

I prefer not to be asked

lol

... you starting to sound like Barry.

I cant believe the postings on the adv.. Mdx threadit makes you wonder how much you can fraudulently steal from investorshow blatant you can perform this actand how uninterested the authorities areits all their bar the handcuffsand the fcuking idiots that uphold the lawcouldnt uphold their dicks sod working for a livingthe authorities with all this information are a disgrace..


Meldex International
Trading Update

Meldex International PLC
24 January 2008



24 January 2008

Meldex International plc

Meldex reports strong trading and operational progress in pre close update

London, UK, 24 January 2008, Meldex International plc ('Meldex', the 'Company'
or the 'Group') (AIM:MDX), the specialty pharmaceutical and healthcare company,
announces strong trading for the year ended 31 December 2007 ahead of the close
period preceding publication of the Group's preliminary results, planned for
announcement during April 2008.

Key Highlights:

Revenue growth of 217 per cent. from 9.5 million in 2006 to 30 million
in 2007 at the top end of equity analyst expectations

Integration of all acquisitions completed; demonstrated by cross
fertilisation of regional products, enhanced distribution partnering
arrangements and successful product launches throughout the Group

Transformational acquisition of the Melbrosin group of companies has
rapidly created a global OTC division

Significant enhancement of portfolio through selective product
acquisitions such as the antacid RocgelTM and antibiotic Alfatil

TabWrapTM, Solupol, Meltums and SoluleavesTM commercial launches

Launch of high growth products including the analgesics range and
nicotine replacement therapy in both prescription and OTC markets
exhibiting early signs of good growth potential

Trading to date in 2008 has been strong


Richard Trevillion, Chief Executive, said:

'Meldex has had a superb trading year in 2007. The Group has out-performed its
own targets and has demonstrated robust and rapid organic growth. The Company's
pipeline and growing portfolio of products provide a strong platform for further
growth in 2008 and beyond.

Key launches of products such as analgesics and the nicotine replacement strip,
benefitting from TabWrapTM, SoluleavesTM and Solupol enabling technologies, have
been successfully achieved. We are excited by our newly acquired brands Rocgel
and Alfatil, our extended analgesic range and other key product developments.
This means that Meldex is well positioned going forward.'

For further information:

Meldex International plc + 44 (0)20 7098 9880
Richard Trevillion, CEO
Steve Martin, CDO
Hiral Patel, CFO

Corfin Communications + 44 (0)20 7977 0020
Martin Sutton

About Meldex International plc

Meldex International plc is an innovative specialty pharmaceutical and Over The
Counter ('OTC') product company. Listed on London's AIM in May 2003, the Company
has over 80 patents granted or in business within 24 patent families and has
product development agreements and strategic alliances with several global
healthcare companies.

Meldex has acquired sales and marketing resources within Europe and the US as a
launch mechanism for its own pharmaceutical products. Meldex acquired the
Melbrosin business in June 2007 for a consideration of up to 35 million.
Melbrosin's focus is on consumer OTC healthcare products based on substances of
natural and plant origin which are developed into consumer orientated brands
then scaled, produced and distributed by Melbrosin. Melbrosin complements the
prescription pharmaceutical sales and marketing business created and expanded in
2006.

The business continues to develop innovative delivery mechanisms enhancing both
its own product range and those of selected partners using its proprietary
XGELTM polymer technology.

For further information please go to www.meldexinternational.com




This information is provided by RNS
The company news service from the London Stock Exchange

---------------------------------------------------------
B J Muncaster - 24 Sep'10 - 13:37 - 16695 of 16713

RT was CEO.

SM was CDO.

RT and SM were tied at the hip.

HP was FD under the control of RT and SM.

JC worked for HP.

Now, for those who think that down-the-line JC or for that matter any manager knew what was going on, go through this little beauty, and there's a lot more like it:

----- Original Message -----
From: Paul F. KENNEDY
To: Steve Martin
Sent: Wed Apr 30 14:14:46 2008
Subject: Invoice for 50,000 Euros.

Steve,

Can you please arrange payment by return.

Thanks.

Paul

Tel 06 09 82 44 13

De : Steve Martin [mailto:Steve.Martin@meldexinternational.com]
Envoy: mercredi 30 avril 2008 15:18
: paulfkennedy@yahoo.co.uk
Cc : richard.trevillion@btopenworld.com
Objet : Re: Invoice for 50,000 Euros.

Paul

I have forwarded this over to Richard who will sort this out.

Regards

Steve

----- Original Message -----
From: Paul F. KENNEDY
To: Steve Martin
Cc: Richard bt
Sent: Wed Apr 30 14:49:19 2008
Subject: RE: Invoice for 50,000 Euros.

Steve,

Thanks.

Given the situation I would obviously appreciate prompt payment.

Regards,

Paul

Tel 06 09 82 44 13
De : Steve Martin [mailto:Steve.Martin@meldexinternational.com]
Envoy: mercredi 30 avril 2008 15:51
: paulfkennedy@yahoo.co.uk
Objet : Re: Invoice for 50,000 Euros.

It will be sorted. We have to sneak it under Hirals radar screen!!!!!!!

Steve
----- Original Message -----
From: Paul F. KENNEDY
To: Steve Martin
Sent: Wed Apr 30 15:00:40 2008
Subject: RE: Invoice for 50,000 Euros.

But presumably Dexo France will need to pay ?

Regards,

Paul

Tel 06 09 82 44 13

De : Steve Martin [mailto:Steve.Martin@meldexinternational.com]
Envoy: mercredi 30 avril 2008 16:05
: paulfkennedy@yahoo.co.uk
Objet : Re: Invoice for 50,000 Euros.

Yes, but HP looks at every invoice so we have to sneak it under the radar screen!!! Just have to play a little game (which should be unnecessary) here. Fear not!

----- Original Message -----
From: Paul F. KENNEDY
To: Steve Martin
Sent: Wed Apr 30 15:09:28 2008
Subject: RE: Invoice for 50,000 Euros.

I trust you.

Try to get it done by next week.

Is the rest ok?

When are you in Paris?

Regards,

Paul

Tel 06 09 82 44 13

-----Original Message-----
From: Steve Martin
Sent: 30 April 2008 15:15
To: 'paulfkennedy@yahoo.co.uk'
Subject: Re: Invoice for 50,000 Euros.

I will do what I can!

I have been in Paris today and on train back. It looked as if I was having 3 or 4 hours spare but I needed to get back with my team. I have some urgent work re the bids etc to get done tonight!!!!

Otherwise it would have been meeting at Gare du Nord in a bar!!!! You would have met Chris Mugglestone my colleague!

I will try and call this evening!

Steve

All been at it from day one tabby and imo still are.

How much pocket money do you think Stevie Baby had put by for the offer?did he run it under Hirals radar screenwas it a lead 1? why wasnt it excepted?


Thursday 17 July, 2008
Meldex International
Potential Offer
RNS Number : 2589Z
Meldex International PLC
17 July 2008




For Immediate Release 17 July 2008


Meldex International plc


Potential Offer


London, UK: Meldex International plc ('the Company'), the specialty pharmaceutical and healthcare company, announces that Steve Martin, the Chief Development Officer and Board member of the Company, has made an approach to the Board of Directors ('the Board') seeking permission to explore the possibility of making an offer for the Company.


There can be no guarantee that this approach will lead to an offer being made for the issued ordinary share capital of the Company, or that any transaction will be recommended by the Board or consummated.


An Independent Committee of the Board has been formed for the purposes of considering any and all offers made. A further announcement will be made in due course.

I wonder who was shorting at this timetuff one?